Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

22 trials with published results (19%)

Research Maturity

59 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.4%

4 terminated out of 117 trials

Success Rate

93.7%

+7.1% vs benchmark

Late-Stage Pipeline

14%

16 trials in Phase 3/4

Results Transparency

37%

22 of 59 completed with results

Key Signals

22 with results94% success

Data Visualizations

Phase Distribution

74Total
Not Applicable (42)
Early P 1 (2)
P 1 (4)
P 2 (10)
P 3 (11)
P 4 (5)

Trial Status

Completed59
Active Not Recruiting18
Unknown16
Recruiting8
Not Yet Recruiting6
Withdrawn5

Trial Success Rate

93.7%

Benchmark: 86.5%

Based on 59 completed trials

Clinical Trials (117)

Showing 20 of 20 trials
NCT03036930Phase 2Active Not RecruitingPrimary

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT06598475Not ApplicableRecruitingPrimary

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

NCT06611540Not ApplicableActive Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT06611553Not ApplicableActive Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT07550010Not ApplicableRecruitingPrimary

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

NCT03309033Active Not RecruitingPrimary

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

NCT06498661Not ApplicableActive Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

NCT07521163Not ApplicableNot Yet Recruiting

Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women

NCT04226313Not ApplicableRecruiting

Self-sampling for Non-attenders to Cervical Cancer Screening

NCT06256718Not ApplicableActive Not RecruitingPrimary

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

NCT07461818Not ApplicableRecruiting

Point of Care - Triage and Treatment for Cervical Pre-cancer

NCT00867464Active Not Recruiting

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

NCT06491446Phase 1Active Not RecruitingPrimary

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

NCT07281430Not ApplicableRecruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT05774561Recruiting

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

NCT01932697Phase 2CompletedPrimary

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

NCT02897427Active Not RecruitingPrimary

Throat and Other HPV-Related Cancers in Men: Identifying Them Early

NCT05057312Not ApplicableActive Not RecruitingPrimary

Promoting HPV Vaccination Among Young Adults in Texas

NCT04474821Phase 4CompletedPrimary

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

NCT07186530Not ApplicableEnrolling By Invitation

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Scroll to load more

Research Network

Activity Timeline